|
|
Other links at Articles > Business of Medicine |
| 2. |
More Action Possible Erythropoiesis-Stimulating Agents: US FDA
|
|
|
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with erythropoiesis-stimulating agents, also known as ESAs or Epo drugs, for anemia. Reuters Health Information
|
| 3. |
Inter-State Physician Licensure System to Be Recommended
|
|
|
A special committee under the National Governors Association is set to tell US governors that states must create a physician licensure system that works across state lines "in a uniform manner," permitting open interaction of physicians with other physicians and patients across boundaries. Medscape Medical News
|
|
|